Key Background Manufactured by Novo Nordisk, Ozempic was approved by the Food and Drug Administration for Type 2 diabetes in 2017, and Wegovy was approved for weight loss in 2021
Low blood sugar (hypoglycemia): Symptoms may include headache, hunger, weakness, sweating, confusion, irritability, dizziness, fast heart rate, or feeling jittery
The products are for research and development purposes only
Tirzepatide shows a lot of promise but should never be taken without the guidance of a medical professional and paired with lifelong changes to your diet and exercise regimen
Neurochemical Research, 37, 16819
While glutathione is generally considered well-tolerated, some individuals may experience: Discomfort at the injection site Digestive changes such as bloating or cramping Headaches or temporary fatigue Rare allergic reactions Excessively high doses, especially when administered too frequently, may interfere with natural antioxidant regulation
